carvacrol
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2020 (NCT05445089)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccc(C(C)C)cc1O- Mol. weight
- 150.22 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL281202 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06806566 | N/A | Feb 1, 2024 | British University In Egypt |
| NCT05445089 | Phase 2/Phase 3 (Phase 3) | Aug 1, 2020 | Biosynthesis Medical, Instituto Venezolano de Investigaciones Cientificas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biosynthesis Medical | Academic/Hospital | 1 | 0 | 1 | 2020 |
| British University In Egypt | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Instituto Venezolano de Investigaciones Cientificas | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1